AVENUE THERAPEUTICS INC - COM NEW (ATXI)

CUSIP: 05360L205

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM NEW
Total 13F shares
220,347
Share change
-16
Total reported value
$624,000
Price per share
$2.82
Number of holders
7
Value change
-$273
Number of buys
3
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 05360L205?
CUSIP 05360L205 identifies ATXI - AVENUE THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AVENUE THERAPEUTICS INC - COM NEW (ATXI) as of Q3 2018

As of 30 Sep 2018, AVENUE THERAPEUTICS INC - COM NEW (ATXI) was held by 7 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 220,347 shares. The largest 7 holders included Vanguard Group Inc, National Asset Management, Inc., Frontier Wealth Management LLC, BlackRock Inc., Granite Point Capital Management, L.P., UBS Group AG, and BANK OF AMERICA CORP /DE/. This page lists 7 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.